LipoMatrix/Collagen Aesthetics Trilucent Breast Implants Withdrawn In UK
This article was originally published in The Gray Sheet
Executive Summary
The UK Department of Health's Medical Devices Agency has advised the withdrawal of Trilucent soybean oil breast implants as a precautionary measure, citing reports of local complications in a small number of women who have received the implant. MDA has ruled that no more of the devices be implanted.
You may also be interested in...
Trilucent Breast Implants Should Be Explanted - UK Medical Devices Agency
Mutagenicity studies conducted by Collagen Aesthetics' LipoMatrix unit on the safety of Trilucent breast implants containing a soybean oil filler material failed to take into account the absence of aged characterized oil and the use of extracts, according to an advisory group to the UK's Medical Devices Agency (MDA).
Trilucent Breast Implants Should Be Explanted - UK Medical Devices Agency
Mutagenicity studies conducted by Collagen Aesthetics' LipoMatrix unit on the safety of Trilucent breast implants containing a soybean oil filler material failed to take into account the absence of aged characterized oil and the use of extracts, according to an advisory group to the UK's Medical Devices Agency (MDA).
Orthopedic, Cardiovascular Registries Lead Worldwide Tracking Endeavors
Most international registries and databases to track use and performance of medical device implants have focused primarly on the orthopedics sector to date.